|
An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)
|
|
W23-093-2
|
|
An Open-label, Long-term, Safety and Efficacy Study of Aticaprant as Adjunctive Therapy in Adult and Elderly Participants With Major Depressive Disorder (MDD)
|
|
Dr. Neha Jain
|
|
This is a clinical study of an investigational medication for adults with Major Depressive Disorder (MDD). The purpose of the study is to evaluate the effectiveness of Aticaprant when used as an add-on treatment for adults with MDD. Study participation lasts 8 weeks and includes a screening phase, a double blinded phase and a follow-up phase. There is also an optional open-label phase study for those who qualify.
|
Psychiatry - General Adult/Mental Health (Depression, Anxiety, Etc.)
|
|
|
Adults 18 years of age or older; have a diagnosis of MDD; have not responded adequately to antidepressant in the current depressive episode; for additional eligibility criteria, check in with study contact.
|
|
Galina Prpich. Telephone: 860-679-7539 Email: prpich@uchc.edu
|
|
Enrolling/recruiting
|
|
|